NovaBay Pharmaceuticals Inc (NBY)
0.077
0.00 (0.00%)
USD |
NYAM |
Apr 23, 16:00
0.0761
0.00 (0.00%)
After-Hours: 04:22
NovaBay Pharmaceuticals Debt to Equity Ratio: 0.3431 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.3431 |
| September 30, 2023 | 0.1805 |
| June 30, 2023 | 0.1384 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.0103 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.0075 |
| June 30, 2020 | 0.531 |
| March 31, 2020 | -6.315 |
| December 31, 2019 | 2.684 |
| September 30, 2019 | 1.042 |
| June 30, 2019 | 1.656 |
| March 31, 2019 | 1.989 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | -0.2124 |
| March 31, 2016 | -0.4196 |
| December 31, 2015 | -0.3246 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-6.315
Minimum
Mar 2020
2.684
Maximum
Dec 2019
0.0146
Average
--
Median
Dec 2020
Debt to Equity Ratio Benchmarks
| Eyenovia Inc | 1.588 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 9.034M |
| Total Liabilities (Quarterly) | 5.72M |
| Shareholders Equity (Quarterly) | 3.314M |
| Current Ratio | 1.672 |
| Net Debt Paydown Yield | -9.93% |